60
Participants
Start Date
March 1, 2024
Primary Completion Date
August 1, 2024
Study Completion Date
August 1, 2024
Bupivacaine 0.25% Injectable Solution
Group CTB (n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25% Group ESPB (n=30): patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%
Sohag University
OTHER